NasdaqGM - Delayed Quote USD
Eton Pharmaceuticals, Inc. (ETON)
At close: October 21 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
42.00
6,815.00
4,821.00
-4,721.00
-22,346.00
--
Investing Cash Flow
-2,657.00
-775.00
-2,788.00
-2,559.00
-50.00
--
Financing Cash Flow
-1,257.00
-957.00
-134.00
391.00
31,625.00
--
End Cash Position
17,694.00
21,388.00
16,305.00
14,406.00
21,295.00
--
Income Tax Paid Supplemental Data
247.00
247.00
--
--
--
--
Interest Paid Supplemental Data
778.00
842.00
730.00
815.00
797.00
--
Capital Expenditure
--
-775.00
-2,788.00
-3,259.00
-50.00
--
Issuance of Capital Stock
--
--
--
--
28,782.00
--
Issuance of Debt
--
--
--
--
2,476.00
4,750.00
Repayment of Debt
-1,540.00
-1,155.00
-385.00
-150.00
--
--
Free Cash Flow
-2,615.00
6,040.00
2,033.00
-7,980.00
-22,396.00
--
12/31/2019 - 11/13/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HROW Harrow, Inc.
56.42
-1.84%
AQST Aquestive Therapeutics, Inc.
4.9500
-1.59%
DERM Journey Medical Corporation
6.32
+3.27%
IRWD Ironwood Pharmaceuticals, Inc.
4.1900
-4.77%
INDV Indivior PLC
8.27
-3.39%
ITCI Intra-Cellular Therapies, Inc.
76.91
-1.83%
ASRT Assertio Holdings, Inc.
1.1500
-0.86%
SUPN Supernus Pharmaceuticals, Inc.
33.67
-2.52%
BFRI Biofrontera Inc.
0.9427
+12.23%
TXMD TherapeuticsMD, Inc.
1.5750
-3.96%